Precision medicine has the potential to transform how we understand and treat autoimmune and inflammatory diseases, but only if we can align innovation with inf...
Continue reading
The way we treat autoimmune and inflammatory diseases is undergoing a fundamental shift. These conditions are deeply heterogeneous. Patients with the same diagn...
Continue reading
Podcast recap: Matt Burgess on genetic counseling, ethics in rare disease, and demystifying genetics
In the most recent episode of The Genetics Podcast, Patrick sits down with fellow podcaster and genetic counselor Matt Burgess. Matt is the host of Demystifying...
Continue reading
Autoimmune diseases include more than 80 conditions defined by immune system dysfunction in which the body mistakenly attacks healthy tissue. Treating autoimmun...
Continue reading
Despite growing momentum behind precision medicine, autoimmune and inflammatory diseases remain some of the most underserved areas in healthcare. Affecting an e...
Continue reading
In a recent episode of The Genetics Podcast, Patrick spoke with Dr. Sal Rico, Chief Medical Officer at Encoded Therapeutics. Having worked across small molecule...
Continue reading
Precision medicine offers more targeted treatments, better patient outcomes, and even the potential to transform how we approach disease. But getting there isn’...
Continue reading
In rare and ultra-rare diseases, data availability is one of the most significant constraints in research and drug development. With thousands of rare condition...
Continue reading
As clinical trials become more complex and patient populations more diverse, the traditional focus on recruitment alone is no longer enough. Building long-term ...
Continue reading
In the latest episode of The Genetics Podcast, Patrick Short chatted with Leeland Ekstrom, CEO and co-founder of Nashville Biosciences (NashBio), a for-profit s...
Continue reading